International Harmonization and Cooperation in the Validation of Alternative Methods.

The development and validation of scientific alternatives to animal testing is important not only from an ethical perspective (implementation of 3Rs), but also to improve safety assessment decision making with the use of mechanistic information of higher relevance to humans. To be effective in these efforts, it is however imperative that validation centres, industry, regulatory bodies, academia and other interested parties ensure a strong international cooperation, cross-sector collaboration and intense communication in the design, execution, and peer review of validation studies. Such an approach is critical to achieve harmonized and more transparent approaches to method validation, peer-review and recommendation, which will ultimately expedite the international acceptance of valid alternative methods or strategies by regulatory authorities and their implementation and use by stakeholders. It also allows achieving greater efficiency and effectiveness by avoiding duplication of effort and leveraging limited resources. In view of achieving these goals, the International Cooperation on Alternative Test Methods (ICATM) was established in 2009 by validation centres from Europe, USA, Canada and Japan. ICATM was later joined by Korea in 2011 and currently also counts with Brazil and China as observers. This chapter describes the existing differences across world regions and major efforts carried out for achieving consistent international cooperation and harmonization in the validation and adoption of alternative approaches to animal testing.

Brazilian Center for the Validation of Alternative Methods (BraCVAM) and the process of validation in Brazil.

The need for the creation of a Brazilian centre for the validation of alternative methods was recognised in 2008, and members of academia, industry and existing international validation centres immediately engaged with the idea. In 2012, co-operation between the Oswaldo Cruz Foundation (FIOCRUZ) and the Brazilian Health Surveillance Agency (ANVISA) instigated the establishment of the Brazilian Center for the Validation of Alternative Methods (BraCVAM), which was officially launched in 2013. The Brazilian validation process follows OECD Guidance Document No. 34, where BraCVAM functions as the focal point to identify and/or receive requests from parties interested in submitting tests for validation. BraCVAM then informs the Brazilian National Network on Alternative Methods (RENaMA) of promising assays, which helps with prioritisation and contributes to the validation studies of selected assays. A Validation Management Group supervises the validation study, and the results obtained are peer-reviewed by an ad hoc Scientific Review Committee, organised under the auspices of BraCVAM. Based on the peer-review outcome, BraCVAM will prepare recommendations on the validated test method, which will be sent to the National Council for the Control of Animal Experimentation (CONCEA). CONCEA is in charge of the regulatory adoption of all validated test methods in Brazil, following an open public consultation.

Assessment of pyrogenic response of lipoteichoic acid by the monocyte activation test and the rabbit pyrogen test.

Lipoteichoic acid (LTA) is a non-endotoxin pyrogen of a great importance in the pathogenesis of sepsis. The Rabbit Pyrogen Test (RPT) is able to detect all types of pyrogens but involves the use of animals. The Bacterial Endotoxin Test (BET) cannot fully replace the RPT because it only detects endotoxins. The Monocyte Activation Test (MAT) is sensitive to all types of pyrogens and it is based on the same biological mechanism that is responsible for the fever reaction in humans. Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) has recommended its use for other pyrogens than endotoxin because its equivalence to RPT can be demonstrated. The aim of this study was to evaluate the pyrogenic responses of the RPT and MAT that was induced by LTA. Different LTA concentrations were assayed by the MAT in parallel to the RPT. The results showed that the MAT was more sensitive than the RPT, demonstrating that the MAT detected LTA. This result may contribute to the acceptance of this test by the Brazilian regulatory agencies as a replacement for the animals used in the RPT.

Participation of Brazil in the World Congresses on Alternatives and Animal Use in the Life Sciences: an increase in commitment to the Three Rs.

Many Brazilian researchers have long been interested in the development and use of alternative methods. Most of their research groups work in isolation, due to the lack of funding for collaborative studies. Despite these problems, since the Third World Congress on Alternatives and Animal Use in the Life Sciences, Brazilian researchers have strongly participated, not only by presenting posters and oral presentations, but also by being involved in the World Congress Committees. The Brazilian Center for the Validation of Alternative Methods (BraCVAM) must play an important role in the development and validation of alternative methods, through the active participation of the National Network of Alternative Methods (ReNaMA). In Brazil, Law 11,794/2008 regulates the use of animals in experimentation and education, and Law 9,605/1998 clearly states that use of the original animal test is not permitted, if an alternative method is available. Therefore, given the current legal framework, it is very important that all the Ministries involved with animal use, and the organisations responsible for funding researchers, strive to increase the financial support of those groups that are involved in the development and use of alternative methods in Brazil.

Influência do erro de micropipetas na dosagem espectrofotométrica do ensaio de endotoxina bacteriana (LAL cromogênico) aplicável a produtos sujeitos à Vigilância Sanitária / Effect of micropipette inaccuracy on performance of spectrophotometric assay for bacteria endotoxin dosage (chromogenic LAL) employed in products subjected to sanitary surveillance

Segundo a norma ISO 17.025, os instrumentos usados em experimento devem ser calibrados. No caso de micropipetas não há limite máximo de erro definido, sendo difícil estipular até que ponto uma micropipeta pode continuar a ser usada. O objetivo do trabalho foi o de determinar a porcentagem de erro no volume da micropipeta que não interfira nos resultados das diferentes etapas do ensaio toxicológico Lisado de Amebócitos de Limulus (LAL). Os percentuais de erro foram obtidos do levantamento de 44 certificados de micropipetas. Foram utilizados uma pipeta monocanal calibrada, de volume variável e kit LAL Cromogênio QCL-1000 (Lonza). A curva de endotoxina foi construída com as concentrações de 0,1; 0,25; 0,5 e 1 UE/mL. Os percentuais de erro de ±2%, ±4% e±10% foram comparados com a concentração de referência (0,5 UE/mL), e analisados pelo Student t-test (p<0,05). A análise estatística mostrou que, para a endotoxina padrão e para o substrato do LAL, erro acima de 2% interferenos resultados, cuja correção deve ser feita pelo ajuste do volume na pipeta. Nenhum erro testado causou interferência estatisticamente significativa na reação da cor do substrato. Micropipetas com erro superior a ±2% devem ser corrigidas.

Caracterização imunofenotípica e avaliação quantitativa do infiltrado linfocítário junto às áreas de displasia epitelial da próstata de cães adultos sexualmente intactos / Immunophenotipic characterization and quantitative evaluation of lymphocitary infiltrate in areas with prostatic epithelial dysplasia of intact and adult dogs

O estudo da próstata canina tem se tornado comum em razão da grande incidência de doenças prostáticas nessa espécie e das similaridades com as alterações apresentadas pela glândula prostática humana. Frente à alta frequência de displasias epiteliais acompanhadas de infiltrado linfocitário intersticial e atrofia acinar na espécie canina, o presente estudo teve como objetivos a caracterização imunofenotípica e a avaliação quantitativa desse infiltrado, utilizando marcadores para identificação de linfócitos T (anti-CD3) e B (anti-CD79a). Foram catalogadas 42 lesões displásicas classificadas em discreta (48 por cento), moderada (38 por cento) e acentuada (14 por cento). O infiltrado linfocitário intersticial periacinar junto às áreas de epitélio prostático displásico constituiu-se predominantemente por linfócitos T (66 por cento) e houve interação entre o grau histológico da displasia e o marcador imunoistoquímico, com oscilação na quantidade de células T e B intersticiais em função do grau da displasia epitelial.

Canine prostatic studies have been common due to high incidence of prostatic diseases in these animals and similarities with alterations in human prostatic gland. Due the high frequency of dysplasia associated with interstitial lymphocitary infiltrate and acinar atrophy in canine prostate, the aims in this study were the immunophenotypic characterization and the quantitative evaluation of the same infiltrated using anti-CD3 and anti-CD79a to T and B lymphocytes, respectively. Forty two epithelial dysplasic lesions were graduated in discrete (48 percent), moderate (38 percent) and accentuated (14 percent). Lymphocitary periacinar infiltrate in dysplasic areas was T type and interaction between dysplasia grade and marker was observed, with oscillation of T and B cells in according with epithelial dysplasia grade.